Top Stories
Optimizing leukemia treatment through pharmaceutical science
Limiting allergic reactions, optimizing treatments and reducing unwanted late effects is part of the pharmaceutical research being conduction to better cancer treatment.
Features
Commercial Appeal’s inaugural Healthcare Newsmaker Breakfast spotlights St. Jude Global
Today, the strongest predictor of whether a child is cured of their disease is where the child is born. St. Jude is committed to increasing pediatric cancer survival rates in low- and middle-income countries to 60% by 2030 for the six most common pediatric cancers.
Research
Optimizing leukemia treatment through pharmaceutical science
Limiting allergic reactions, optimizing treatments and reducing unwanted late effects is part of the pharmaceutical research being conduction to better cancer treatment.
Clinical Care
‘Black hole’ of cancer journey? Transition oncology program fills the gap
Transition from cancer treatment to everyday life isn’t as easy as it seems, for parents or...
Education & Training
Patient safety: Best practices in combining quality improvement and continuing medical education
Patient safety processes and systems are enhanced through these frank discussions between clinicians and caregivers.
Popular Posts
Cancer drugs for children in critically short supply
Chemotherapy agents are consistently among the drug classes in short supply, and it threatens the treatment of children with cancer.
Recent Posts
Recent Videos
